Table 1.
CON | ||
---|---|---|
Po2mvBL, mmHg | 28.4 ± 1.1 | 31.6 ± 1.2* |
Δ1Po2mv, mmHg | 10.5 ± 0.9 | 12.7 ± 0.8* |
Po2mv (steady state), mmHg | 18.0 ± 0.9 | 18.9 ± 1.2 |
TD1, s | 7.0 ± 1.2 | 6.0 ± 1.6 |
τ1, s | 12.3 ± 1.2 | 19.7 ± 2.2* |
MRT1, s | 19.3 ± 1.9 | 25.6 ± 3.3* |
Δ2Po2mv, mmHg | 3.4 ± 0.5 | 2.9 ± 0.1 |
TD2, s | 78.5 ± 22.3 | 68.9 ± 9.5 |
τ2, s | 67.9 ± 7.7 | 77.1 ± 14.2 |
MRT2, s | 146.4 ± 25.7 | 97.3 ± 48.8 |
Values are means ± SE. Po2mvBL, resting Po2mv; Δ1Po2mv and Δ2Po2mv, amplitude of the first and second components; Po2mv(steady state), contracting steady-state Po2mv; TD1 and TD2, time delay of the first and second component; τ1, and τ2, time constant of the first and second component; MRT1 and MRT2, mean response time of the first and second component. Primary components were calculated for all rats (n = 12). Secondary components were present in 3 control (CON) and 2 rats.
P ≤ 0.05 vs. CON.